End-to-end platform Slope offers a fully integrated, vendor-agnostic biospecimen and clinical inventory lifecycle solution, presenting a compelling upsell for sponsors, CROs, and sites looking to consolidate systems and reduce waste.

Waste reduction leadership Proven ability to reclaim up to three quarters of wasted lab kits and achieve high site adoption, which can be highlighted to prospective customers aiming to cut trial costs and improve protocol adherence.

Global site reach Trusted by over 2,200 sites across 23 countries, signaling scalable deployment potential and opportunities to win multi-regional deals or expand existing deployments with cross-border trial programs.

Recent collaborations Recent partnerships with Florence Healthcare and launched tech-enabled services indicate a growing ecosystem and potential for co-sell or integration-focused opportunities with complementary platforms.

Growth signals Revenue in the mid-range tens of millions with a notable funding base positions Slope as a credible, growing target for strategic partnerships, channel alliances, and potential investment conversations.